FMT Combined With Standard First-Line Therapy in Initially Unresectable Colorectal Cancer

FMT Combined With Standard First-Line Therapy in Initially Unresectable Colorectal Cancer is a phase 2/3, randomised interventional study registered as NCT07509398 by Shanghai 10th People's Hospital, with a registry enrolment figure of 220 participants, started 2026-04 and due to reach its primary completion in 2027-12. Interventions recorded: Standard First-Line Therapy; FMT Combined with Standard First-Line Therapy. Conditions listed: Unresectable Colorectal Cancer; Colorectal Cancer (Locally Advanced or Metastatic). Primary outcome: Objective Response Rate. Colorectal eligibility wording from the registry: "(3) Meet the defined criteria for initially unresectable advanced metastatic colorectal cancer (mCRC) for this project". No results are recorded here; the registry entry is the source.